MANSFIELD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced successful completion of an oversubscribed Seed financing round of $4.7M. This round included participation from existing investors Thairm Bio, Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and new undisclosed investors.

马萨诸塞州曼斯菲尔德，2024年7月11日（环球通讯社）--3Daughters，Inc.，一家为女性提供进化医疗服务的临床开发公司，宣布成功完成了一轮470万美元的超额认购种子融资。这一轮包括现有投资者Thairm Bio、Argosy Foundation、Wexford Science and Technology，LLC、麻省大学阿默斯特分校和新的未披露投资者的参与。

Previously, the company had announced the close of the first tranche of this financing round, exceeding $2 million. The additional investor participation underscores the growing significance and need for innovation in Women’s Health and particularly for contraception, a growing $8 billion dollar market in the U.S.

此前，该公司已宣布本轮融资的第一部分结束，金额超过200万美元。投资者的额外参与突显了女性健康创新的重要性和必要性，尤其是避孕，这是美国一个不断增长的80亿美元市场。

Women use contraceptives on average for 30 years and improved options are needed. Mary Beth Cicero, CEO of 3Daughters, commented, “We are thrilled by the overwhelming response from both our existing and new investors who share our determination and dedication to improving therapies for women, starting with our advanced IUD and integrated system for insertion and retrieval.

女性平均使用避孕药具30年，需要改进选择。3Daughters首席执行官玛丽·贝思·西塞罗（MaryBethCicero）评论道：“我们对现有和新投资者的压倒性反应感到兴奋，他们分享了我们改进女性治疗的决心和奉献精神，从我们先进的宫内节育器和插入和取出的集成系统开始。

Notably, this oversubscribed round supports our preclinical development through an IND filing in early 2025, a major milestone in our development timeline.” Research indicates that over 275 million women worldwide use intrauterine devices (IUDs), with copper IUDs being the most popular choice for non-hormonal, long acting, and reversible contraception.

值得注意的是，这轮超额认购通过2025年初的IND申请支持了我们的临床前发展，这是我们发展时间表上的一个重要里程碑。”研究表明，全世界有超过2.75亿女性使用宫内节育器，其中铜宫内节育器是非激素、长效和可逆避孕最受欢迎的选择。

3Daughters’ lead asset (3D-001) is a frameless, non-hormonal, magnetic IUD that self-assembles when placed in the uterus and conforms to a woman’s body. 3D-001 is paired with a patented inserter and retriever designed as an integrated system to eliminate the three major pain points during the IUD insertion process.

3Daughters的lead asset（3D-001）是一种无框架的非激素磁性宫内节育器，放置在子宫内时会自我组装，并符合女性的身体。3D-001与专利插入器和取回器配套，设计为一个集成系统，以消除宫内节育器插入过程中的三个主要痛点。

A recent Wall Street Journal artic.

《华尔街日报》最近的一篇文章。